Delpor
Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson's, Alzheimer's, and MS.
Contact Name:
Tassos Nicolaou
Contact Email:
Website:
https://www.delpor.com
City, State – Congressional District:
Brisbane,
CA
–
14
Technology:
Drug,
Medical Device
Funding:
Diabetes, Digestive, and Kidney (NIDDK),
Drug Abuse (NIDA),
Mental Health (NIMH),
Neurological Disorders and Stroke (NINDS)
NIH Projects:
NIH RePorter for
Delpor
Sponsored Event(s):
BIO | 2020
,
Biotech Showcase | 2024
,
Landmark Social Impact | 2022
,
RESI/LifeScience Nation | 2021
